Inari Medical Begins DEFIANCE Randomized Clinical Trial of ClotTriever System in DVT
January 12, 2023—Inari Medical, Inc. announced that the first patient has been enrolled in the DEFIANCE prospective randomized controlled trial (RCT) comparing the clinical outcomes of patients with iliofemoral deep vein thrombosis (DVT) treated with the company’s ClotTriever system versus anticoagulation only.
